Premyelinated central axons express neurotoxic NMDA receptors: Relevance to early developing white-matter injury

Journal of Cerebral Blood Flow and Metabolism

Volumn 35, Issue 4, 2015, Pages 543-553

  Huria, Tahani ^a   Beeraka, Narasimha Murthy ^a   Al Ghamdi, Badrah ^a   Fern, Robert ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

axon; glutamate; ischemia; white matter

Indexed keywords

IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CALCIUM TRANSPORT; CONTROLLED STUDY; EXCITOTOXICITY; FETUS; HUMAN; HUMAN CELL; IMMUNOGOLD LABELING; MYELINATION; NERVE CELL EXCITABILITY; NERVE FIBER; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SODIUM TRANSPORT; WHITE MATTER INJURY; ANIMAL; AXON; BRAIN ISCHEMIA; MYELINATED NERVE; PATHOLOGY; WHITE MATTER;

ANIMALS; AXONS; BRAIN ISCHEMIA; HUMANS; NERVE FIBERS, MYELINATED; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; WHITE MATTER;

EID: 84926524217     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.227     Document Type: Article

References (49)

1. Schmitz Y, Luccarelli J, Kim M, Wang M, Sulzer D. Glutamate controls growth rate and branching of dopaminergic axons. J Neurosci 2009; 29: 11973-11981.
2. Ehlers MD, Fung ET, O'Brien RJ, Huganir RL. Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J Neurosci 1998; 18: 720-730.
3. Herkert M, Rottger S, Becker CM. The NMDA receptor subunit NR2B of neonatal rat brain: complex formation and enrichment in axonal growth cones. Eur J Neurosci 1998; 10: 1553-1562.
4. Wang PY, Petralia RS, Wang YX, Wenthold RJ, Brenowitz SD. Functional NMDA receptors at axonal growth cones of young hippocampal neurons. J Neurosci 2011; 31: 9289-9297.
5. Aoki C, Venkatesan C, Go CG, Mong JA, Dawson TM. Cellular and subcellular localization of NMDA-R1 subunit immunoreactivity in the visual cortex of adult and neonatal rats. J Neurosci 1994; 14: 5202-5222.
6. Dean JM, Fraser M, Shelling AN, Bennet L, George S, Shaikh S et al. Ontogeny of AMPA and NMDA receptor gene expression in the developing sheep white matter and cerebral cortex. Brain Res Mol Brain Res 2005; 139: 242-250.
7. Fern R, Davis P, Waxman SG, Ransom BR. Axon conduction and survival in CNS white matter during energy deprivation: a developmental study. J Neurophysiol 1998; 79: 95-105.
8. Back SA. Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Ment Retard Dev Disabil Res Rev 2006; 12: 129-140.
9. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009; 8: 110-124.
10. Babcock MA, Kostova FV, Ferriero DM, Johnston MV, Brunstrom JE, Hagberg H et al. Injury to the preterm brain and cerebral palsy: clinical aspects, molecular mechanisms, unanswered questions, and future research directions. J Child Neurol 2009; 24: 1064-1084.
11. Drobyshevsky A, Jiang R, Lin L, Derrick M, Luo K, Back SA et al. Unmyelinated axon loss with postnatal hypertonia after fetal hypoxia. Ann Neurol 2014; 75: 533-541.
12. Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate Injury. Nature 2005; 438: 1167-1171.
13. Karadottir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005; 438: 1162-1166.
14. Alix JJ, Fern R. Glutamate receptor-mediated ischemic injury of premyelinated central axons. Ann Neurol 2009; 66: 682-693.
15. Alix JJ, Zammit C, Riddle A, Meshul CK, Back SA, Valentino M et al. Central axons preparing to myelinate are highly sensitivity to ischemic injury. Ann Neurol 2012; 72: 936-951.
16. Alix JJ, Dolphin AC, Fern R. Vesicular apparatus, including functional calcium channels, are present in developing rodent optic nerve axons and are required for normal node of Ranvier formation. J Physiol 2008; 586: 4069-4089.
17. Fern R. Intracellular calcium and cell death during ischemia in neonatal rat white matter astrocytes in situ. J Neurosci 1998; 18: 7232-7243.
18. Zecevic N. Synaptogenesis in layer I of the human cerebral cortex in the first half of gestation. Cereb Cortex 1998; 8: 245-252.
19. 2+ exchanger. J Neurosci 1992; 12: 430-439.
20. Tekkok SB, Ye Z, Ransom BR. Excitotoxic mechanisms of ischemic injury in mye-linated white matter. J Cereb Blood Flow Metab 2007; 27: 1540-1552.
21. Mi H, Barres BA. Purification and characterization of astrocyte precursor cells in the developing rat optic nerve. J Neurosci 1999; 19: 1049-1061.
22. Small RK, Riddle P, Noble M. Evidence for migration of oligodendrocyte-type-2 astrocyte progenitor cells into the developing rat optic nerve. Nature 1987; 328: 155-157.
23. Skoff RP, Price DL, Stocks A. Electron microscopic autoradiographic studies of gliogenesis in rat optic nerve. II. Time of origin. J Comp Neurol 1976; 169: 313-334.
24. Khwaja O, Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 2008; 93: F153-F161.
25. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC et al. Late oli-godendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001; 21: 1302-1312.
26. Jakovcevski I, Zecevic N. Sequence of oligodendrocyte development in the human fetal telencephalon. Glia 2005; 49: 480-491.
27. Hildebrand C, Waxman SG. Postnatal differentiation of rat optic nerve fibers: electron microscopic observations on the development of nodes of Ranvier and axoglial relations. J Comp Neurol 1984; 224: 25-37.
28. Wierzba-Bobrowicz T, Lechowicz W, Kosno-Kruszewska E. A morphometric evaluation of morphological types of microglia and astroglia in human fetal mesencephalon. Folia Neuropathol 1997; 35: 29-35.
29. Roessmann U, Gambetti P. Astrocytes in the developing human brain. An immunohistochemical study. Acta Neuropathol 1986; 70: 308-313.
30. Jakovcevski I, Filipovic R, Mo Z, Rakic S, Zecevic N. Oligodendrocyte development and the onset of myelination in the human fetal brain. Front Neuroanat 2009; 3: 5.
31. Haynes RL, Borenstein NS, Desilva TM, Folkerth RD, Liu LG, Volpe JJ et al. Axonal development in the cerebral white matter of the human fetus and infant. J Comp Neurol 2005; 484: 156-167.
32. Huppi PS, Maier SE, Peled S, Zientara GP, Barnes PD, Jolesz FA et al. Micro-structural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr Res 1998; 44: 584-590.
33. Buser JR, Segovia KN, Dean JM, Nelson K, Beardsley D, Gong X et al. Timing of appearance of late oligodendrocyte progenitors coincides with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia-ischemia. J Cereb Blood Flow Metab 2010; 30: 1053-1065.
34. Zecevic N, Chen Y, Filipovic R. Contributions of cortical subventricular zone to the development of the human cerebral cortex. J Comp Neurol 2005; 491: 109-122.
35. Back SA, Miller SP. Brain injury in premature neonates: a primary cerebral dys-maturation disorder? Ann Neurol 2014; 75: 469-486.
36. Billiards SS, Haynes RL, Folkerth RD, Borenstein NS, Trachtenberg FL, Rowitch DH et al. Myelin abnormalities without oligodendrocyte loss in periventricular leu-komalacia. Brain Pathol 2008; 18: 153-163.
37. Buser JR, Maire J, Riddle A, Gong X, Nguyen T, Nelson K et al. Arrested pre-oligodendrocyte maturation contributes to myelination failure in premature infants. Ann Neurol 2012; 71: 93-109.
38. Lee S, Leach MK, Redmond SA, Chong SY, Mellon SH, Tuck SJ et al. A culture system to study oligodendrocyte myelination processes using engineered nanofibers. Nat Methods 2012; 9: 917-922.
39. Kinney HC, Karthigasan J, Borenshteyn NI, Flax JD, Kirschner DA. Myelination in the developing human brain: biochemical correlates. Neurochem Res 1994; 19: 983-996.
40. Meng SZ, Arai Y, Deguchi K, Takashima S. Early detection of axonal and neuronal lesions in prenatal-onset periventricular leukomalacia. Brain Dev 1997; 19: 480-484.
41. Hirayama A, Okoshi Y, Hachiya Y, Ozawa Y, Ito M, Kida Y et al. Early immuno-histochemical detection of axonal damage and glial activation in extremely immature brains with periventricular leukomalacia. Clin Neuropathol 2001; 20: 87-91.
42. Haynes RL, Billiards SS, Borenstein NS, Volpe JJ, Kinney HC. Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker Fractin. Pediatr Res 2008; 63: 656-661.
43. Dammann O, Hagberg H, Leviton A. Is periventricular leukomalacia an axono-pathy as well as an oligopathy? Pediatr Res 2001; 49: 453-457.
44. Riddle A, Maire J, Gong X, Chen KX, Kroenke CD, Hohimer AR et al. Differential susceptibility to axonopathy in necrotic and non-necrotic perinatal white matter injury. Stroke 2012; 43: 178-184.
45. Wilke S, Thomas R, Allcock N, Fern R. Mechanism of acute ischemic injury of oligodendroglia in early myelinating white matter: the importance of astrocyte injury and glutamate release. J Neuropathol Exp Neurol 2004; 63: 872-881.
46. Back SA, Craig A, Kayton RJ, Luo NL, Meshul CK, Allcock N et al. Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J Cereb Blood Flow Metab 2006; 27: 334-347.
47. Hermann R, Walther P, Muller M. Immunogold labeling in scanning electron microscopy. Histochem Cell Biol 1996; 106: 31-39.
48. Fatokun AA, Smith RA, Stone TW. Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons. Brain Res 2008; 1215: 200-207.
49. Manning SM, Talos DM, Zhou C, Selip DB, Park HK, Park CJ et al. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 2008; 28: 6670-6678.